Works matching IS 00178748 AND DT 2022 AND VI 62 AND IP 4
Results: 15
Erratum.
- Published in:
- 2022
- Publication type:
- Correction Notice
Fremanezumab in individuals with chronic migraine who had inadequate response to onabotulinumtoxinA and topiramate or valproic acid.
- Published in:
- Headache: The Journal of Head & Face Pain, 2022, v. 62, n. 4, p. 530, doi. 10.1111/head.14294
- By:
- Publication type:
- Article
Current practice for primary headache disorders and perspectives on peripheral nerve blocks among emergency physicians in Canada: A national survey.
- Published in:
- Headache: The Journal of Head & Face Pain, 2022, v. 62, n. 4, p. 512, doi. 10.1111/head.14293
- By:
- Publication type:
- Article
Challenges and complexities in designing cluster headache prevention clinical trials: A narrative review.
- Published in:
- Headache: The Journal of Head & Face Pain, 2022, v. 62, n. 4, p. 453, doi. 10.1111/head.14292
- By:
- Publication type:
- Article
A real‐world, observational study of erenumab for migraine prevention in Canadian patients.
- Published in:
- Headache: The Journal of Head & Face Pain, 2022, v. 62, n. 4, p. 522, doi. 10.1111/head.14291
- By:
- Publication type:
- Article
Do behavioral treatments work for migraine prevention?
- Published in:
- Headache: The Journal of Head & Face Pain, 2022, v. 62, n. 4, p. 402, doi. 10.1111/head.14290
- By:
- Publication type:
- Article
Real‐world assessment of the relationship between migraine‐related disability and healthcare costs in the United States.
- Published in:
- Headache: The Journal of Head & Face Pain, 2022, v. 62, n. 4, p. 473, doi. 10.1111/head.14289
- By:
- Publication type:
- Article
Are psychological interventions efficacious for adults with migraine? A systematic review and meta‐analysis.
- Published in:
- Headache: The Journal of Head & Face Pain, 2022, v. 62, n. 4, p. 405, doi. 10.1111/head.14260
- By:
- Publication type:
- Article
Asking the right questions: The value of headache specialty care.
- Published in:
- Headache: The Journal of Head & Face Pain, 2022, v. 62, n. 4, p. 401, doi. 10.1111/head.14288
- Publication type:
- Article
Cluster headache pathophysiology: What we have learned from advanced neuroimaging.
- Published in:
- Headache: The Journal of Head & Face Pain, 2022, v. 62, n. 4, p. 436, doi. 10.1111/head.14279
- By:
- Publication type:
- Article
To test or not to test? Do red flags play any role?
- Published in:
- Headache: The Journal of Head & Face Pain, 2022, v. 62, n. 4, p. 399, doi. 10.1111/head.14275
- By:
- Publication type:
- Article
Red flags in headache care.
- Published in:
- Headache: The Journal of Head & Face Pain, 2022, v. 62, n. 4, p. 534, doi. 10.1111/head.14273
- Publication type:
- Article
Erenumab dosage for migraine prevention: An evidence‐based narrative review with recommendations.
- Published in:
- Headache: The Journal of Head & Face Pain, 2022, v. 62, n. 4, p. 420, doi. 10.1111/head.14266
- By:
- Publication type:
- Article
Network meta‐analysis of therapies for cluster headache: Effects of acute therapies for episodic and chronic cluster.
- Published in:
- Headache: The Journal of Head & Face Pain, 2022, v. 62, n. 4, p. 482, doi. 10.1111/head.14283
- By:
- Publication type:
- Article
Issue Information.
- Published in:
- Headache: The Journal of Head & Face Pain, 2022, v. 62, n. 4, p. 1, doi. 10.1111/head.14158
- Publication type:
- Article